1. Home
  2. WRAP vs CNTX Comparison

WRAP vs CNTX Comparison

Compare WRAP & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WRAP
  • CNTX
  • Stock Information
  • Founded
  • WRAP 2016
  • CNTX 2015
  • Country
  • WRAP United States
  • CNTX United States
  • Employees
  • WRAP N/A
  • CNTX N/A
  • Industry
  • WRAP Ordnance And Accessories
  • CNTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • WRAP Industrials
  • CNTX Health Care
  • Exchange
  • WRAP Nasdaq
  • CNTX Nasdaq
  • Market Cap
  • WRAP 91.2M
  • CNTX 77.2M
  • IPO Year
  • WRAP N/A
  • CNTX 2021
  • Fundamental
  • Price
  • WRAP $2.00
  • CNTX $0.97
  • Analyst Decision
  • WRAP
  • CNTX Strong Buy
  • Analyst Count
  • WRAP 0
  • CNTX 5
  • Target Price
  • WRAP N/A
  • CNTX $6.70
  • AVG Volume (30 Days)
  • WRAP 313.3K
  • CNTX 1.1M
  • Earning Date
  • WRAP 11-14-2024
  • CNTX 11-06-2024
  • Dividend Yield
  • WRAP N/A
  • CNTX N/A
  • EPS Growth
  • WRAP N/A
  • CNTX N/A
  • EPS
  • WRAP N/A
  • CNTX N/A
  • Revenue
  • WRAP $4,231,000.00
  • CNTX N/A
  • Revenue This Year
  • WRAP N/A
  • CNTX N/A
  • Revenue Next Year
  • WRAP N/A
  • CNTX N/A
  • P/E Ratio
  • WRAP N/A
  • CNTX N/A
  • Revenue Growth
  • WRAP N/A
  • CNTX N/A
  • 52 Week Low
  • WRAP $1.21
  • CNTX $0.89
  • 52 Week High
  • WRAP $7.01
  • CNTX $2.75
  • Technical
  • Relative Strength Index (RSI)
  • WRAP 55.21
  • CNTX 36.02
  • Support Level
  • WRAP $1.95
  • CNTX $0.92
  • Resistance Level
  • WRAP $2.15
  • CNTX $1.05
  • Average True Range (ATR)
  • WRAP 0.18
  • CNTX 0.13
  • MACD
  • WRAP -0.01
  • CNTX 0.01
  • Stochastic Oscillator
  • WRAP 56.90
  • CNTX 12.04

About WRAP Wrap Technologies Inc.

Wrap Technologies Inc offers public safety technologies and services. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: